Holen Sie sich die Stockscreener-App
499.74
1.77%
-9.01
Finanzdaten der Vertex Pharmaceuticals Inc-Aktie (VRTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
11.62%
3,333.90
|
2,986.90 | 3,190.00 | 3,076.40 | 2,964.70 |
| Cost Of Revenue |
24.54%
489.20
|
392.80 | 466.00 | 414.80 | 407.50 |
| Selling, General, and Administrative |
17.93%
582.20
|
493.70 | - | - | - |
| Costs And Expenses |
12.88%
2,087.00
|
1,848.80 | 1,984.10 | 1,890.20 | 1,813.60 |
| Operating Income/Loss |
9.56%
1,246.90
|
1,138.10 | 1,205.90 | 1,186.20 | 1,151.10 |
| Income/Loss From Continuing Operations Before Tax |
11.09%
1,391.80
|
1,252.90 | 1,331.00 | 1,298.80 | 1,283.00 |
| Income Tax Expense/Benefit |
31.83%
292.00
|
221.50 | 139.90 | 215.90 | 250.10 |
| Net Income/Loss |
6.63%
1,099.80
|
1,031.40 | 1,191.10 | 1,082.90 | 1,032.90 |
| Basic Average Shares |
0.16%
253.70
|
254.10 | -0.70 | 255.60 | 256.70 |
| Diluted Average Shares |
0.43%
255.20
|
256.30 | -0.60 | 257.60 | 258.90 |
| Basic Earnings Per Share |
6.90%
4.34
|
4.06 | 4.69 | 4.24 | 4.02 |
| Diluted Earnings Per Share |
7.21%
4.31
|
4.02 | 4.64 | 4.20 | 3.99 |
7.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):